7% Off
Rimactane450 mg
SANDOZ (A Novartis Division)
৳10.10
Out Of Stock
Generic medicine
Rifampicin: Brands, Price & Uses in Bangladesh
Established / Guideline-Supported Uses Tuberculosis (TB): Rifampicin is a cornerstone, first-line antitubercular agent.
About Rifampicin
Indications of Rifampicin
Established / Guideline-Supported Uses
- Tuberculosis (TB): Rifampicin is a cornerstone, first-line antitubercular agent. It is always used as part of a multi-drug combination regimen (typically with isoniazid, pyrazinamide, and ethambutol in the initial intensive phase, followed by Rifampicin plus isoniazid in the continuation phase). Rifampicin is never used as monotherapy for active TB because resistance develops rapidly.
- Prophylaxis of meningococcal carriers: Rifampicin is used to eliminate Neisseria meningitidis from the nasopharynx of asymptomatic carriers to prevent spread, in close contacts of a case of meningococcal disease. It is not used to treat active meningococcal disease itself.
- Prophylaxis against Haemophilus influenzae type b (Hib): given to close contacts (including children) to reduce the risk of invasive Hib disease, per public health guidance.
Adjunct / Combination-Only Uses
- Leprosy (Hansen's disease): Rifampicin is a key component of WHO multidrug therapy (MDT) regimens, always combined with dapsone (and clofazimine for multibacillary disease). It is not used alone for leprosy.
- Serious staphylococcal infections (e.g., prosthetic device or bone/joint infections): occasionally added as an adjunct to another active antistaphylococcal antibiotic to improve biofilm penetration; not used as a single agent because resistance emerges quickly.
- Brucellosis: used in combination with doxycycline (or other agents) per treatment guidelines.
Off-Label Use
- Legionella pneumonia (severe cases, as an adjunct to a macrolide or fluoroquinolone) and select other atypical or resistant bacterial infections may use Rifampicin off-label in combination therapy, based on specialist assessment.
Rifampicin should only be prescribed by, or under the direct guidance of, a physician experienced in managing these infections.
Dosage & Administration of Rifampicin
General Administration
Rifampicin is usually taken on an empty stomach (1 hour before or 2 hours after meals) with a full glass of water to maximize absorption, unless gastrointestinal upset requires taking it with food. It should always be given as part of a properly designed combination regimen for tuberculosis and leprosy; it should never be used alone to treat active infection.
| Indication | Adult Dose | Pediatric Dose |
|---|---|---|
| Tuberculosis (with companion drugs) | 10 mg/kg once daily (maximum 600 mg/day), oral or IV | 10-20 mg/kg once daily (maximum 600 mg/day) |
| Meningococcal carrier prophylaxis | 600 mg every 12 hours for 2 days (4 doses total) | Age ≥1 month: 10 mg/kg every 12 hours for 2 days (max 600 mg/dose). Age <1 month: 5 mg/kg every 12 hours for 2 days |
| Leprosy (WHO MDT, with dapsone ± clofazimine) | 600 mg once monthly (supervised dose), per WHO regimen | Weight-based per WHO pediatric MDT chart |
Duration
Duration of TB treatment is typically at least 6 months (2-month intensive phase plus at least 4-month continuation phase), and may be extended for certain forms of TB (e.g., meningitis, bone/joint disease) per physician guidance. Leprosy MDT duration is 6-12 months or longer depending on classification.
Renal and Hepatic Considerations
- Renal impairment: Rifampicin is predominantly eliminated hepatically/biliary, so dose adjustment is generally not required in renal impairment; caution and dose reduction may be considered in severe renal impairment on high-dose regimens, per physician judgment.
- Hepatic impairment: use with caution and only if clearly necessary in patients with pre-existing liver disease; more frequent liver function monitoring is required (see Precautions and Warnings).
Important Stewardship Reminder
Take Rifampicin exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice. Missing doses or stopping treatment early is a leading cause of treatment failure and multidrug-resistant tuberculosis.
Side Effects of Rifampicin
Common
- Harmless orange-red discoloration of urine, tears, sweat, saliva, and sputum (patients should be counseled about this in advance; it can permanently stain soft contact lenses)
- Gastrointestinal upset: nausea, vomiting, abdominal discomfort, diarrhea, loss of appetite
- Headache, dizziness, drowsiness
Less Common but Clinically Important
- Hepatotoxicity: elevated liver enzymes, hepatitis, jaundice (see Precautions and Warnings)
- "Flu-like syndrome" (fever, chills, myalgia, headache) — more common with intermittent (less than daily) dosing schedules
- Hypersensitivity reactions: rash, pruritus, urticaria; rarely, severe cutaneous reactions
- Hematologic effects: thrombocytopenia, hemolytic anemia, leukopenia (rare)
- Renal effects: interstitial nephritis, acute kidney injury (rare, more common with intermittent high-dose regimens or with resumption after interruption)
Patients should seek prompt medical attention for yellowing of skin/eyes, unusual bleeding or bruising, severe rash, or persistent fever, as these may indicate a serious reaction.
Contraindications of Rifampicin
- Known hypersensitivity to Rifampicin or to any other rifamycin antibiotic (e.g., rifabutin, rifapentine).
- Concurrent use with certain HIV protease inhibitors where Rifampicin's potent enzyme induction causes clinically significant loss of antiviral efficacy or a risk of severe hepatotoxicity, specifically ritonavir-boosted saquinavir, and (per prescribing information) atazanavir, darunavir, fosamprenavir, saquinavir, and tipranavir — such combinations should be avoided; an alternative antitubercular or antiretroviral regimen should be selected in consultation with a specialist.
Rifampicin is not recommended as monotherapy for active tuberculosis or leprosy under any circumstance, as this is not a true contraindication but a well-established rule of use (see Indications and Dosage and Administration).
Frequently Asked Questions about Rifampicin
Why do I need to take other medicines along with Rifampicin for my TB treatment?
Rifampicin is always used together with other antitubercular drugs (such as isoniazid, pyrazinamide, and ethambutol) because using Rifampicin alone allows tuberculosis bacteria to rapidly develop resistance. The combination regimen kills the bacteria more effectively and prevents drug resistance.
Why has my urine, sweat, or tears turned orange-red after starting Rifampicin?
This is a well-known, harmless side effect of Rifampicin. It causes an orange-red discoloration of body fluids including urine, sweat, tears, and saliva. It does not indicate any organ damage, but it can permanently stain soft contact lenses, so it is best to avoid wearing them during treatment.
Can I stop taking Rifampicin once I feel better?
No. You must complete the full course of Rifampicin exactly as prescribed by your physician, which is often 6 months or longer for tuberculosis, even if your symptoms improve much earlier. Stopping early, skipping doses, or taking it irregularly is a leading cause of treatment failure and multidrug-resistant tuberculosis (MDR-TB), which is much harder to treat. Never stop, extend, skip doses, or share this medicine with others without your physician's advice.
Will Rifampicin affect my birth control pills?
Yes. Rifampicin is a strong inducer of liver enzymes that break down hormonal contraceptives, which can significantly reduce their effectiveness and increase the risk of unintended pregnancy. If you take Rifampicin, you should discuss using an alternative or additional non-hormonal method of contraception with your physician during treatment and for some time afterward.
Is Rifampicin safe during pregnancy or breastfeeding?
Rifampicin should be used during pregnancy only if clearly needed and if your physician determines that the benefit outweighs the potential risk to the baby — for example, when treating active tuberculosis in a pregnant woman. If Rifampicin is given close to delivery, there is a risk of postnatal bleeding, so your physician may recommend vitamin K. For breastfeeding, small amounts of Rifampicin pass into breast milk; discuss with your physician, who will weigh the benefits of continuing both treatment and breastfeeding against any theoretical risk.
What should I do if I think I have taken too much Rifampicin?
An overdose of Rifampicin is a medical emergency. Seek immediate medical attention or contact your local emergency services or poison control center right away. Do not try to treat it at home. Signs of overdose may include nausea, vomiting, abdominal pain, severe drowsiness, and a marked reddish-brown discoloration of the skin and urine.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.